[Ferritin, CEA and TPA as tumor markers in breast neoplasms].
In order to assess the sensitivity and specificity of Ferritin, CEA and TPA as neoplastic markers in breast carcinomas, 91 patients all classified according to the TNM-UICC system were studied in a cancer clinic. The results of the analyses indicate that ferritin is apparently only influenced by the presence of metastatic neoplasias and that greater sensitivity is obtained if all three markers are employed simultaneously.
D000915:Antibody Affinity; D001943:Breast Neoplasms / Q000276:immunology*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D005293:Ferritins / Q000032:analysis*; D006801:Humans; D009362:Neoplasm Metastasis / Q000276:immunology; D010455:Peptides / Q000032:analysis*; D019396:Tissue Polypeptide Antigen
D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen; D005293:Ferritins
Ferritina-CEA-TPA come markers neoplastici nelle neoplasie mammarie.